EN | RU
EN | RU

Help Support

Back

News

News

63
Regulatory News

FDA releases alert regarding invasive disease risk in preterm infants receiving...

As per the FDA, the administration of probiotics formulated to contain live bacteria or yeast to preterm infants in hospital settings poses a significant risk o...

74
Regulatory News

WHO recommends multivitamins for pregnancy in updated essential medicines list

WHO has updated its Essential Medicines List to include a range of essential multivitamins and micronutrient supplements for pregnant women, aiming to enhance m...

162
Regulatory News

FDA greenlights first biosimilar for multiple sclerosis treatment

For the management of multiple sclerosis, the FDA has granted approval to the first biosimilar (Natalizumab-sztn).

72
Regulatory News

WHO recommends Rituximab off-label use in multiple sclerosis

WHO has endorsed groundbreaking public health measures concerning novel Essential Medicines for the treatment of multiple sclerosis.

62
Regulatory News

FDA greenlights first-ever oral medication for postpartum depression

Zuranolone has received FDA approval for addressing postpartum depression in adults.

84
Regulatory News

FDA approves revolutionary cellular therapy, Lantidra, for type 1 diabetes treat...

FDA approval of Lantidra offers hope to adults suffering from type 1 diabetes who struggle with severe hypoglycemia, despite intensive management efforts.

44
Regulatory News

RSV vaccine wins FDA approval for people aged 60 years and above

In older adults, FDA has authorized the first Respiratory Syncytial Virus vaccine to prevent lower respiratory tract illness.

75
Regulatory News

FDA thumbs up to a recent breakthrough in treatment of knee osteoarthritis

A new implantable shock absorber can help individuals with symptomatic knee osteoarthritis for easing pain and relish their lifestyle and interests.

49
Regulatory News

Unique FDA-approved therapy for constipation. Read to know!

Novel vibrating therapy may be used to ease constipation without the use of any drugs.

58
Regulatory News

Lecanemab-irmb gets accelerated FDA approval for Alzheimer's Disease

FDA has given accelerated approval to Lecanemab-irmb for Alzheimer’s disease management.

55
Regulatory News

Albuterol/Budesonide Combination Rescue Inhaler gets FDA approval for asthma

For the as-needed management or prophylaxis of bronchoconstriction and to lessen asthma episodes risk in asthma-affected people (18 years of age and older), the...

43
Regulatory News

First gene therapy for Hemophilia B receives FDA approval

For management of Hemophilia B in adults, the FDA has authorized a single-dose gene therapy Etranacogene dezaparvovec.

Try: